GLP-1 medications carry an FDA boxed warning for personal or family history of medullary thyroid carcinoma (MTC) or MEN2, based on rodent studies for both semaglutide and tirzepatide
While numerous proof-of-concept candidate molecules have been disclosed (43), the only approved example of multi-receptor agonism for obesity and T2D is the dual GLP-1R/GIPR co-agonist tirzepatide (marketed as Mounjaro and Zepbound ) (44)
Your provider decides the strength, how often to use it, and whether it makes sense for your skin
Drinking adequate water throughout the daytypically 1012 cups for most adultshelps stabilize blood volume and electrolyte balance, both of which influence blood vessel function and migraine susceptibility
Understanding what to expect during your first month helps you stay committed while your body adapts to this powerful medication
Additionally, it should be used with caution in patients with a history of gallbladder disease